VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Zuanek & Associates
Equibles does not estimate personal net worth.
Pablo Zuanek is recorded as Analyst at Zuanek & Associates. Pablo Zuanek has spoken on 9 earnings calls across 7 companies, most recently for Marimed Inc. on August 13, 2026. Those appearances were for Vireo Growth Inc. (VREOF), NewLake Capital Partners, Inc. (NLCP), Marimed Inc. (MRMD), Organigram Global Inc. (OGI), Cresco Labs Inc. (CRLBF) and 2 other companies. The companies whose calls Pablo Zuanek spoke on are classified in the Healthcare and Real Estate sectors.
“Let's start with, can you drill down on the performance of your Illinois stores? And maybe for the audience, remind people of how many stores you have in Illinois.”
“Jonah, thank you very much for those prepared remarks. I think you gave a great caller that explains the strategy. So that was very, very helpful.”
“Anthony, can we start by talking about leap times? I'm thinking about Georgia, Virginia, Texas. You know, when supposedly in the case of Georgia, flower is already legal since allowed since July 1st, right?”
“Look, I just want to go back to the guidance commentary on the moving from 300 to 350 million. How much of that 50 million is coming from the higher spread capture now, which will have been from OGI product right now being sold towards the downstream?”
“But do you really expect normalization as you defined it in this administration?”
Zuanek & Associates
Analyst
Transcript header (unverified)
VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
MRMD
Drug Manufacturers - Specialty & Generic · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
CRLBF
Drug Manufacturers - Specialty & Generic · Healthcare
CURLF
Drug Manufacturers - Specialty & Generic · Healthcare
TLRY
Drug Manufacturers - Specialty & Generic · Healthcare